Tetra Radar · FDA Approvals · Decision date
povetacicept: FDA decision date
Vertex Pharmaceuticals Inc / Ma (VRTX) · 30 November 2026
FDA’s review of our biologics license application for accelerated approval of povetacicept with an assigned PDUFA . target action date of November 30, 2026;.
Source: 10-Q of 3 November 2026
The decision is pending.
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.